Drug details

Duaklir Pressair (aclidinium bromide and formoterol fumarate inhalation powder)

type of Respiratory Inhalant Combos, Respiratory Inhalant Combos

Duaklir Pressair (aclidinium bromide and formoterol fumarate) is a combination of an anticholinergic and a long-acting beta2-adrenergic agonist (LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

The drug is often used to treat Chronic obstructive pulmonary disease .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• chest pain,
• blurred vision,
• itching
• fainting,
• weakness,
• fast or irregular heartbeat,
• muscle cramps,
• rash, and
• eye pain,
• increased thirst or urination,
• seeing halos around lights,
• severe dizziness,
• difficult or painful urination,
• sudden severe wheezing,
• increased trouble breathing after using the medication,
• swelling or redness of the eye,

The following drugs are related to Duaklir Pressair, either as a replacement or used together:

• Alvesco (ciclesonide inhalation aerosol)
• Anoro Ellipta (umeclidinium and vilanterol inhalation powder)
• Arnuity Ellipta (fluticasone furoate inhalation powder)
• Asmanex (mometasone furoate)
• Qvar (beclomethasone dipropionate hfa)
• Qvar Redihaler (beclomethasone dipropionate hfa inhalation aerosol)
• Breztri Aerosphere (budesonide, glycopyrrolate, and formoterol fumarate inhalation aerosol)
• Pulmicort Turbuhaler (budesonide)
• Symbicort (budesonide and formoterol fumarate dihydrate)
• Pulmicort Flexhaler (budesonide inhalation powder)
• Pulmicort Respules (budesonide inhalation suspension)
• Trelegy Ellipta (fluticasone furoate inhalation powder)